$18.34
0.60%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.

Sotera Health Co Target price 2026 - Analyst rating & recommendation

Sotera Health Co Classifications & Recommendation

Buy
80%
Hold
20%

Sotera Health Co Price Target

Target Price $23.92
Price $18.34
Potential
Number of Estimates 11
11 Analysts have issued a price target Sotera Health Co 2027 . The average Sotera Health Co target price is $23.92. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 12 Analysts recommend Sotera Health Co to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sotera Health Co stock has an average upside potential 2027 of . Most analysts recommend the Sotera Health Co stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 1.16 1.26
5.74% 8.20%
EBITDA Margin 33.75% 51.28%
3.27% 51.92%
Net Margin 6.70% 22.54%
66.26% 236.47%

12 Analysts have issued a sales forecast Sotera Health Co 2026 . The average Sotera Health Co sales estimate is

$1.3b
unlock
. This is
3.52% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.3b 7.96%
unlock
, the lowest is
$1.2b 0.07%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $1.2b 5.74%
2026
$1.3b 8.20%
unlock
2027
$1.3b 5.96%
unlock
2028
$1.4b 5.92%
unlock
2029
$1.5b 5.59%
unlock

12 Analysts have issued an Sotera Health Co EBITDA forecast 2026. The average Sotera Health Co EBITDA estimate is

$646m
unlock
. This is
56.96% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$672m 63.47%
unlock
, the lowest is
$625m 52.00%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $393m 9.20%
2026
$646m 64.38%
unlock
2027
$687m 6.36%
unlock
2028
$732m 6.56%
unlock
2029
$779m 6.42%
unlock

EBITDA Margin

2025 33.75% 3.27%
2026
51.28% 51.92%
unlock
2027
51.48% 0.39%
unlock
2028
51.79% 0.60%
unlock
2029
52.19% 0.77%
unlock

12 Sotera Health Co Analysts have issued a net profit forecast 2026. The average Sotera Health Co net profit estimate is

$284m
unlock
. This is
73.59% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$297m 81.45%
unlock
, the lowest is
$273m 66.96%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $78.0m 75.80%
2026
$284m 264.05%
unlock
2027
$310m 9.17%
unlock
2028
$340m 9.83%
unlock
2029
$363m 6.73%
unlock

Net Margin

2025 6.70% 66.26%
2026
22.54% 236.47%
unlock
2027
23.22% 3.02%
unlock
2028
24.08% 3.70%
unlock
2029
24.34% 1.08%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.27 0.99
68.75% 266.67%
P/E 18.44
EV/Sales 5.65

12 Analysts have issued a Sotera Health Co forecast for earnings per share. The average Sotera Health Co EPS is

$0.99
unlock
. This is
73.68% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$1.04 82.46%
unlock
, the lowest is
$0.96 68.42%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.27 68.75%
2026
$0.99 266.67%
unlock
2027
$1.09 10.10%
unlock
2028
$1.19 9.17%
unlock
2029
$1.27 6.72%
unlock

P/E ratio

Current 32.18 83.53%
2026
18.44 42.69%
unlock
2027
16.89 8.41%
unlock
2028
15.38 8.94%
unlock
2029
14.41 6.31%
unlock

Based on analysts' sales estimates for 2026, the Sotera Health Co stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.85 2.45%
2026
5.65 3.44%
unlock
2027
5.33 5.62%
unlock
2028
5.03 5.59%
unlock
2029
4.77 5.29%
unlock

P/S ratio

Current 4.30 9.00%
2026
4.16 3.40%
unlock
2027
3.92 5.62%
unlock
2028
3.70 5.59%
unlock
2029
3.51 5.29%
unlock

Current Sotera Health Co Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barclays
Locked
➜
Locked
Locked Aug 07 2026
Piper Sandler
Locked
➜
Locked
Locked Aug 07 2026
Citigroup
Locked
➜
Locked
Locked Aug 07 2026
JP Morgan
Locked
➜
Locked
Locked Aug 07 2026
Barclays
Locked
➜
Locked
Locked Jun 24 2026
Goldman Sachs
Locked
➜
Locked
Locked Jun 05 2026
Piper Sandler
Locked
➜
Locked
Locked May 06 2026
Analyst Rating Date
Locked
Barclays:
Locked
➜
Locked
Aug 07 2026
Locked
Piper Sandler:
Locked
➜
Locked
Aug 07 2026
Locked
Citigroup:
Locked
➜
Locked
Aug 07 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 07 2026
Locked
Barclays:
Locked
➜
Locked
Jun 24 2026
Locked
Goldman Sachs:
Locked
➜
Locked
Jun 05 2026
Locked
Piper Sandler:
Locked
➜
Locked
May 06 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today